Because of the relatively high frequency of Factor V Leiden heterozygosity in Caucasian populations, this report suggests that dual-factor thrombophilia due to its combination with criteria or noncriteria antiphospholipid antibodies may be more common than is recognized. The gene discussed is F5; the disease is Rare hereditary thrombophilia.